168 related articles for article (PubMed ID: 36865690)
1. Safety of
Kamin W; Behre U; Helm K; Reling B; Funk P; Malek FA
Front Pediatr; 2023; 11():1107984. PubMed ID: 36865690
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of DW1601 in patients with acute bronchitis: a multi-center, randomized, double-blind, phase III clinical trial.
Lee YS; Lim SY; Min KH; Kim DJ; Yoo KH; Kim TB; Kim HR; Shim JJ
Korean J Intern Med; 2022 Nov; 37(6):1195-1204. PubMed ID: 36153858
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EPs 7630): a randomised, double-blind, placebo-controlled, multicentre study.
Matthys H; Heger M
Curr Med Res Opin; 2007 Feb; 23(2):323-31. PubMed ID: 17288687
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of EPs 7630 tablets in patients with acute bronchitis: a randomised, double-blind, placebo-controlled dose-finding study with a herbal drug preparation from Pelargonium sidoides.
Matthys H; Lizogub VG; Malek FA; Kieser M
Curr Med Res Opin; 2010 Jun; 26(6):1413-22. PubMed ID: 20387996
[TBL] [Abstract][Full Text] [Related]
5. Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children.
Matthys H; Kamin W; Funk P; Heger M
Phytomedicine; 2007; 14 Suppl 6():69-73. PubMed ID: 17184981
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial.
Matthys H; Eisebitt R; Seith B; Heger M
Phytomedicine; 2003; 10 Suppl 4():7-17. PubMed ID: 12807337
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial.
Han KI; Kim TH; Ra SW; Yoon HK; Kim DK; Rhee CK; Park JW; Hwang YI; Park HY; Kim YH; Park YB; Shin KC; Lim SY; Yoo KH
Curr Med Res Opin; 2024 Jun; ():1-9. PubMed ID: 38889376
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - a randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides roots.
Kamin W; Maydannik V; Malek FA; Kieser M
Int J Clin Pharmacol Ther; 2010 Mar; 48(3):184-91. PubMed ID: 20197012
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): a randomized, double-blind, placebo-controlled trial.
Chuchalin AG; Berman B; Lehmacher W
Explore (NY); 2005 Nov; 1(6):437-45. PubMed ID: 16781588
[TBL] [Abstract][Full Text] [Related]
10.
Careddu D; Pettenazzo A
Int J Gen Med; 2018; 11():91-98. PubMed ID: 29563828
[TBL] [Abstract][Full Text] [Related]
11. Pelargonium sidoides preparation EPs 7630 in COPD: health-related quality-of-life and other patient-reported outcomes in adults receiving add-on therapy.
Matthys H; Funk P
Curr Med Res Opin; 2018 Jul; 34(7):1245-1251. PubMed ID: 29231073
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
13. Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial.
Willcox M; Simpson C; Wilding S; Stuart B; Soilemezi D; Whitehead A; Morgan A; Wrixon E; Zhu S; Yao G; Webley F; Yan R; Bostock J; Bell M; Griffiths G; Leydon G; Little P; Butler C; Hay AD; Moore M
BMC Complement Med Ther; 2021 Jan; 21(1):48. PubMed ID: 33514367
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute bronchitis with EPs 7630: randomized, controlled trial in children and adolescents.
Kamin W; Ilyenko LI; Malek FA; Kieser M
Pediatr Int; 2012 Apr; 54(2):219-26. PubMed ID: 22360575
[TBL] [Abstract][Full Text] [Related]
15. Treatment with EPs 7630, a
Riley DS; Lizogub VG; Heger M; Funk P; Mueller H; Lehmacher W
Integr Med (Encinitas); 2019 Feb; 18(1):42-51. PubMed ID: 31341433
[TBL] [Abstract][Full Text] [Related]
16. Positioning of the Bronchitis Severity Score (BSS) for standardised use in clinical studies.
Matthys H; Kamin W
Curr Med Res Opin; 2013 Oct; 29(10):1383-90. PubMed ID: 23927521
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis.
Kamin W; Maydannik VG; Malek FA; Kieser M
Acta Paediatr; 2010 Apr; 99(4):537-43. PubMed ID: 20070280
[TBL] [Abstract][Full Text] [Related]
18. EPs 7630 improves acute bronchitic symptoms and shortens time to remission. Results of a randomised, double-blind, placebo-controlled, multicentre trial.
Matthys H; Funk P
Planta Med; 2008 May; 74(6):686-92. PubMed ID: 18449849
[TBL] [Abstract][Full Text] [Related]
19. EPs 7630-solution--an effective therapeutic option in acute and exacerbating bronchitis.
Matthys H; Heger M
Phytomedicine; 2007; 14 Suppl 6():65-8. PubMed ID: 17184984
[TBL] [Abstract][Full Text] [Related]
20. EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited.
Kamin W; Funk P; Seifert G; Zimmermann A; Lehmacher W
Curr Med Res Opin; 2018 Mar; 34(3):475-485. PubMed ID: 29119837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
